VIDEO

FindCenter AddIcon

Dr. Robin Carhart Harris: Psilocybin and the Psychedelic State

By Robin Carhart-Harris — 2013

Dr. Robin Carhart-Harris, of the Neuropsychopharmacology Unit, Imperial College London, discusses research on Psilocybin and how psychedelics could be used in therapy to help with depression, addiction, and other problems of rigid thought patterns.

17:18 min

05:38

The Push to Decriminalize ‘Magic Mushrooms’

Denver the first U.S. city to decriminalize psilocybin, the psychoactive ingredient in so-called magic mushrooms.

FindCenter AddIcon
04:35

‘Default Mode Network’ Is Suppressed by Meditation Practice | Roland Griffiths

It is Dr. Patrick’s goal to challenge the status quo and encourage the wider public to think about health and longevity using a proactive, preventative approach.

FindCenter AddIcon
01:01:21

Psychedelics: Treating Addiction, Depression and Anxiety with Dr. Roland Griffiths

Psychedelics were the subject of serious medical research in the 1940s to the 1960s, when many scientists believed some of the mind-bending compounds held tremendous therapeutic promise for treating a number of conditions including severe mental health problems and alcohol addiction.

FindCenter AddIcon
54:19

Robin Carhart-Harris - Psychedelic Drugs in Science and Medicine

New research using psychedelic drugs to understand the brain could lead to new treatments for mental disorders such as depression.

FindCenter AddIcon
27:57

How Psychedelics Can Treat Depression - Robin Carhart Harris

The talk will review brain imaging work on the action of psychedelics on the brain and describe the results of a clinical trial assessing psilocybin as a treatment for depression. It will also review the broader societal impact of psychedelic drug-use and discuss its implications.

FindCenter AddIcon
16:26

Psychedelics: Lifting the Veil | Robin Carhart-Harris | TEDxWarwick

Robin has been conducting pioneering brain imaging studies of psychedelic drugs. Most recently, he has completed the first phase of a clinical trial looking at the potential of psilocybin to treat depression, and his talk looks at how these drugs can be used in treatment.

FindCenter AddIcon
01:02:06

James Fadiman & Sophia Korb: Microdosing - the Phenomenon, Research Results & Startling Surprises

A six-day global gathering of the international scientific community in Oakland, California to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical marijuana, and more.

FindCenter AddIcon

EXPLORE TOPIC

Altered States of Consciousness